Bone density changes with once weekly risedronate in postmenopausal women.
about
Advanced glycation end products play adverse proinflammatory activities in osteoporosisRisedronate for prevention and treatment of osteoporosis in postmenopausal women.Update on osteoporosis therapy.DXA scanning in clinical practice.Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy.
P2860
Bone density changes with once weekly risedronate in postmenopausal women.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Bone density changes with once weekly risedronate in postmenopausal women.
@ast
Bone density changes with once weekly risedronate in postmenopausal women.
@en
type
label
Bone density changes with once weekly risedronate in postmenopausal women.
@ast
Bone density changes with once weekly risedronate in postmenopausal women.
@en
prefLabel
Bone density changes with once weekly risedronate in postmenopausal women.
@ast
Bone density changes with once weekly risedronate in postmenopausal women.
@en
P2093
P356
P1476
Bone density changes with once weekly risedronate in postmenopausal women.
@en
P2093
Jacyln Shaw
Meryl S LeBoff
Miriam F Delaney
Shelley Hurwitz
P356
10.1385/JCD:6:1:45
P577
2003-01-01T00:00:00Z